Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. - Barritt AS 4th; Tapper EB; Newsome PN; Gazis D; Morris H; Mospan AR; Perez AD; Kim Y; Neuschwander-Tetri BA; Loomba R; Sanyal A (The American journal of gastroenterology, 2026)